CVS Health Corporation (CVS) Financial Statements
CVS Health Corporation (CVS) reported trailing twelve-month revenue of $415.1B (up 7.4% year on year) and net income of $4.9B as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $11.8B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CVSCVS Health CorporationFollow CVS — free
—
Price chart with a free account
- Market cap
- 119.5B
- P/E TTM
- 24.6
- Dividend yield
- 2.8%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 98.22 | 95.78 | 107.08 | 123.12 | 126.76 | 139.37 | 153.29 | 177.55 | 184.79 | 194.58 | 256.78 | 268.71 | 292.11 | 322.47 | 357.78 | 372.81 | 402.07 | 415.09 | |
| Gross profit | 20.36 | 20.22 | 20.56 | 22.49 | 23.78 | 25.37 | 26.53 | 28.86 | 28.55 | 38.13 | 98.06 | 104.73 | 116.31 | 125.58 | 140.68 | 166.52 | 180.90 | 184.68 | |
| Operating income | 6.43 | 6.14 | 6.33 | 7.21 | 8.04 | 8.80 | 9.48 | 10.39 | 9.54 | 4.02 | 11.99 | 13.91 | 13.31 | 7.95 | 13.74 | 8.52 | 4.66 | 8.29 | |
| Pre-tax income | 5.90 | 5.60 | 5.75 | 6.31 | 7.53 | 7.68 | 8.62 | 8.64 | 8.27 | 1.41 | 9.00 | 9.77 | 10.54 | 5.84 | 11.17 | 6.15 | 2.14 | 5.79 | |
| Income tax | 2.20 | 2.18 | 2.26 | 2.44 | 2.93 | 3.03 | 3.39 | 3.32 | 1.64 | 2.00 | 2.37 | 2.57 | 2.55 | 1.51 | 2.81 | 1.56 | 0.41 | 0.90 | |
| Net income | 3.70 | 3.43 | 3.46 | 3.86 | 4.59 | 4.64 | 5.24 | 5.32 | 6.62 | -0.59 | 6.63 | 7.18 | 8.00 | 4.31 | 8.34 | 4.61 | 1.77 | 4.89 | |
| Diluted EPS ($) | 2.55 | 2.49 | 2.57 | 3.02 | 3.74 | 3.96 | 4.63 | 4.90 | 6.44 | -0.57 | 5.08 | 5.46 | 6.02 | 3.26 | 6.47 | 3.66 | 1.39 | 3.80 | |
| Diluted shares (bn) | 1.450 | 1.377 | 1.347 | 1.280 | 1.226 | 1.169 | 1.126 | 1.079 | 1.024 | 1.044 | 1.305 | 1.314 | 1.329 | 1.323 | 1.290 | 1.262 | 1.271 | — |
USD billions · SEC XBRL
CVS Health Corporation — questions
- What is CVS Health Corporation's revenue?
- $415.1B over the twelve months to 2026-06-30, up 7.4% year on year, from its 10-Q and 10-K filings.
- What is CVS Health Corporation's net income?
- $4.9B over the twelve months to 2026-06-30.
- What is CVS Health Corporation's free cash flow?
- $11.8B over the twelve months to 2026-06-30.
- What are CVS Health Corporation's diluted earnings per share?
- $3.80 over the twelve months to 2026-06-30.
Every figure on this page comes from CVS Health Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.